Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
948.87
-13.39 (-1.39%)
At close: Apr 28, 2026
4.34%
Market Cap 50.98B
Revenue (ttm) 27.71B
Net Income (ttm) 4.13B
Shares Out 52.98M
EPS (ttm) 77.92
PE Ratio 12.35
Forward PE 11.66
Dividend 50.00 (5.20%)
Ex-Dividend Date Apr 22, 2026
Volume 13,547
Average Volume 63,435
Open 961.00
Previous Close 962.26
Day's Range 945.03 - 989.74
52-Week Range 755.56 - 1,241.00
Beta 0.08
RSI 51.92
Earnings Date Apr 6, 2026

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, allergy, respiratory, and urology; and generic products under various brands. The company operates in Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, Dubai, Sudan, an... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,563
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2025, Highnoon Laboratories's revenue was 27.71 billion, an increase of 12.44% compared to the previous year's 24.64 billion. Earnings were 4.13 billion, an increase of 21.83%.

Financial Statements

News

There is no news available yet.